Ligand Pharmaceuticals Inc (LGND)

Change in Working Capital

-$7.00M

Quarterly · Period ending: · USD

LGND logo

LGND Change in Working Capital

Latest reported-$7.00M
LGND Quarterly Change in Working Capital ($2.10M → -$7.00M)
High-resolution chart · PNG

LGND change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
-7,001,000
5,885,000
9,289,000
-10,615,000
-6,171,000
-5,168,000
11,602,000
-633,000
-7,610,000
8,243,000
-15,991,000
-20,832,000
-5,476,000
7,897,000
26,572,000
5,011,000
-14,697,000
48,791,000
-14,005,000
-13,806,000
-14,013,000
-15,180,000
-22,456,000
2,159,000
-1,520,000
1,313,000
-40,482,000
-27,023,000
-71,124,000
134,414,000
-37,422,000
-13,707,000
-3,741,000
16,016,000
-10,187,000
3,536,000
-10,015,000
5,228,000
-6,193,000
5,447,000
-809,000
-9,065,000
-729,000
-1,403,000
1,827,000
1,126,000
-2,340,000
-4,139,000
-486,000
-3,984,000
3,776,000
-5,214,000
3,150,000
-2,414,000
-1,870,000
-194,000
-376,000
-328,000
-124,000
-603,000
5,669,000
-10,817,000
-3,663,000
-8,852,000
591,000
-12,814,000
-15,351,000
5,796,000
8,226,000
-17,000,000
11,589,000
-9,825,000
-725,000
-2,345,000
-8,673,000
-11,487,000
-18,442,000
-17,230,000
-184,715,000
-19,164,000
4,220,000
116,998,000
10,503,000
8,240,000
-3,496,000
11,388,000
38,796,000
-2,183,000
-1,094,000
5,673,000
-2,510,000
4,633,000
11,166,000
1,574,000
-5,272,000
1,546,000
-4,096,000
1,009,000
421,000
-3,545,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.